Amwill Healthcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Amwill Healthcare IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹ 8.04 and post-issue EPS of ₹ 6.27 for FY24. The pre-issue P/E ratio is 13.81x, while the post-issue P/E ratio is 17.71x against the Industry P/E ratio is 36x. The company's ROCE for FY24 is 94.16%, ROE for FY24 is 73.06% and RoNW 73.06%. The Annualised EPS based on the latest financial data is ₹ 8.36 and PE ratio is 13.27x. These metrics suggest that the IPO is fairly priced.

Key Performance Indicator

KPI Values
EPS Pre IPO (Rs.) ₹8.04
EPS Post IPO (Rs.) ₹6.27
P/E Pre IPO 13.81
P/E Post IPO 17.71
ROE 73.06%
ROCE 94.16%
P/BV 3.06
Debt/Equity 0.01
RoNW 73.06%

Services

Option Trading with CA Abhay

Equity Trading with CA Abhay

FNO Stocks with CA Abhay

Equity Investment with CA Abhay

Stock Market Masterclass

Services

FNO Stocks with CA Abhay

Option Trading with CA Abhay

Equity Trading with CA Abhay

Stock Market Masterclass

Equity Investment with CA Abhay

onlyfans leakedonlyfan leaksonlyfans leaked videos